Over, under, or just right? How do we interpret ICD utilization in the modern era?

Research output: Contribution to journalEditorialpeer-review

Abstract

Over 5 million individuals are afflicted with heart failure in the United States per year. Current guidelines based on the MADIT- I and II, MUSTT and SCDHeFT trials recommend the use of pharmacologic as well as implantable cardioverter defibrillator (ICD) therapy as Class I indications for the prevention of sudden cardiac death (SCD) in a subgroup of patients (depending on their ejection fraction, NYHA class, and a variety of other parameters). However, despite these guidelines, the use of ICDs has been reported as suboptimal in prior publications as well as in the article by Pillarisetti, et al in this issue of the Journal.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalIndian Pacing and Electrophysiology Journal
Volume15
Issue number1
DOIs
StatePublished - 2015

Keywords

  • Defibrillator
  • Heart failure
  • Sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Over, under, or just right? How do we interpret ICD utilization in the modern era?'. Together they form a unique fingerprint.

Cite this